Skip to main content
Letters in Drug Design & Discovery publishes original letters on all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of Internet technology for both the submission and review of manuscripts. The journal is essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 1, 2012

Articles

Free Content Graphical Abstracts
pp. i-v(5)
Author: Bentham Science Publishers

Favourites:
ADD

Free Content Editorial
pp. 1-1(1)
Author: Atta-ur-Rahman

Favourites:
ADD

Design and Synthesis of 3-Arylisoxazoline-5-Carboxamide and 3-Arylisoxazoline-5-Acetamide Libraries as Potential Factor Xa Inhibitors
pp. 2-7(6)
Authors: F. Quinn, John; T. Gregg, Brian; B. Kitchen, Douglas; M. Lewis, Robert; A. Razzano, Dana; E. Kayser, Lauren; J. Schilling, Levon; C. Golden, Kathryn

Favourites:
ADD

Antioxidant Activity of Resveratrol Analogs
pp. 8-11(4)
Authors: Oliveira Calil, Natalia; Senra Goncalves de Carvalho, Gustavo; Cristina Zimmermann Franco, Danielle; David da Silva, Adilson; Rezende Barbosa Raposo, Nadia

Favourites:
ADD

Semi-Automatic Synthesis of Distamycin Analogues and their DNA Binding Properties
pp. 12-16(5)
Authors: Drozdowska, Danuta; Szerszenowicz, Jakub

Favourites:
ADD

Ligand and Structure-Based Pharmacophore Modeling for the Discovery of Potential Human HNMT Inhibitors
pp. 17-29(13)
Authors: Elumalai, Pavadai; Liu, Hsuan-Liang; Zhou, Zheng-Li; Zhao, Jian-Hua; Chen, Wilson; Chuang, Chih-Kuang; Tsai, Wei-Bor; Ho, Yih

Favourites:
ADD

Synthesis and Anti-Paracoccidioides Activity of Calix[n]arenes
pp. 30-36(7)
Authors: Coimbra de Oliveira, Marcilene; Souza Reis, Fabiano; de Fatima, Angelo; Furtado Ferreira Magalhaes, Thais; Leticia da Silva, Danielle; Rodrigues Porto, Raphael; Almeida Watanabe, Giselle; Viviane Buzanello Martins, Cleide; Leite da Silva, Daniel; Lucia Tasca Gois Ruiz, Ana; Antonio Fernandes, Sergio; Ernesto de Carvalho, Joao; Aparecida de Resende-Stoianoff, Maria

Favourites:
ADD

Preliminary Evaluation of Anticonvulsant Activity of Some Aminoalkanol and Amino Acid Cinnamic Acid Derivatives
pp. 37-43(7)
Authors: Gunia, Agnieszka; M. Waszkielewicz, Anna; Cegla, Marek; Marona, Henryk

Favourites:
ADD

Discovery of 5,6-Dihydro-indolo[1,2-a]quinoxaline Derivatives as New HIV-1 Inhibitors In Vitro
pp. 44-47(4)
Authors: Fan, Ling-Ling; Huang, Ning; Yang, Rui-Ge; He, Shu-Zhen; Yang, Liu-Meng; Xu, Hui; Zheng, Yong-Tang

Favourites:
ADD

Evaluation of the Radioprotective Potential of the Polyphenol Norbadione A
pp. 48-53(6)
Authors: Le Roux, Antoine; Josset, Elodie; Benzina, Sami; Nadal, Brice; Desage-El Murr, Marine; Heurtaux, Benoit; Taran, Frederic; Denis, Jean-Marc; Le Gall, Thierry; Meunier, Stephane; Bischoff, Pierre

Favourites:
ADD

Lobeline Docking on AChBP and Nicotinic Receptors: Discriminating Importance of the Pocket Geometry and of the Ligand Configuration
pp. 54-62(9)
Authors: Colas, Claire; Brotel, Xavier; Duclert-Savatier, Nathalie; Nilges, Michael; Joseph, Delphine; E. Malliavin, Therese

Favourites:
ADD

Synthesis and Biological Evaluation of Some Novel Thiazolylhydrazinomethylideneferrocenes as Antimicrobial Agents
pp. 63-68(6)
Authors: Chandak, Navneet; Kumar, Pawan; Sharma, Chetan; R. Aneja, Kamal; K. Sharma, Pawan

Favourites:
ADD
Favourites:
ADD

Design, Synthesis and Biological Evaluation of Scutellarein Derivatives as Potential Anti-Alzheimer's Disease Candidates Based on Metabolic Mechanism
pp. 78-83(6)
Authors: Song, Shu-Lin; Li, Nian-Guang; Tang, Yu-Ping; Wang, Zhen-Jiang; Qian, Li-Hua; Tang, Hao; Duan, Jin-Ao

Favourites:
ADD

Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy
pp. 84-125(42)
Authors: N. Noolvi, Malleshappa; M. Patel, Harun

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content